Brand-name vs compounded
Gala vs Ro.co: Brand-Name or Compounded? (2026)
Compare Gala and Ro.co on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Gala and Ro.co both prescribe GLP-1 medication online, take payment directly from the patient and ship to the door. That is where the overlap stops.
The dividing line is regulatory, not cosmetic: Ro.co works with product the FDA has reviewed and approved, while Gala runs on compounded medication prepared by a pharmacy rather than manufactured under an approved application. Everything else about the two — price, support, shipping — follows from that decision.
This comparison works from what each provider publishes: the entry price, what it becomes at month two, the medication actually dispensed, and what is bundled rather than billed. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest ongoing rate
- Ro.co — $39/mo against $249/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Ro.co — FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — a finished product the FDA has reviewed, rather than a compounded preparation.
- Fastest route to a first shipment
- Ro.co — Online consultation, then home delivery.
- Most support included
- Gala — Provider check-ins and dose monitoring included.
Side-by-side comparison
Nothing in this table is our estimate. Where a provider does not publish something, the cell says so.
| Gala | Ro.co | |
|---|---|---|
| Advertised price | From $249/mo, as low as $179/mo on longer plans | Get started online for $39 |
| Rate after promotions | $249/mo | $39/mo |
| Pricing structure | Cheaper per month the longer you commit | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables |
| Shipping | Home delivery | Home delivery |
| Support model | Provider check-ins included | Provider check-ins included |
| Tirzepatide | Not published | Not published |
| Price transparency | Published upfront | Partly published |
| Patient reviews | 2,870 | 40,215 |
| eRxDoctor score | 7.7/10 | 7.5/10 |
What you will have spent by month twelve
The advertised rate answers the wrong question. These are the totals — six months and twelve — using each provider's own published rates and best available plan.
| Gala | Ro.co | |
|---|---|---|
| First month | $249 | $39 |
| Months 2 onward | $249/mo | Not published |
| 6-month total | $1,494 | Not computable |
| 12-month total | $2,988 | Not computable |
| Best published plan | longer-term plan at $179/mo — $2,148/yr | No multi-month discount published |
A like-for-like annual total is not available for Ro.co: ongoing medication pricing varies by plan and is set after the consultation. Treat any comparison that quotes one as an estimate someone else has made for you.
What is actually in the vial
Ro.co dispenses FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables: an approved finished drug, meaning the agency has reviewed both the evidence behind it and the facility that makes it.
Gala supplies compounded semaglutide and compounded tirzepatide — compounded medication prepared by a pharmacy rather than manufactured under an approved application. That is what makes $249/mo possible in the first place, and it is also why the oversight is not the same.
Neither choice is wrong, but they are different risks. Paying $39/mo buys regulatory certainty. Paying less buys access, on terms where the manufacturing oversight is not the same.
Gala in detail
Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery.
The process is fully online, no in-office visits, then home delivery. On money, expect cheaper per month the longer you commit — published upfront.
Behind the prescription sits provider check-ins and dose monitoring included. Available medication: compounded semaglutide and compounded tirzepatide.
Gala pros
- Provider check-ins and dose monitoring included
- Direct-pay model, no insurance or prior authorizations needed
- Fully online, no in-office visits required
Gala cons
- Higher entry price than several compounded competitors
- Lower long-term pricing requires a multi-month commitment
Read next to Ro.co, the weak point: the entry price sits above most compounded competitors unless you commit to a longer term.
How Ro.co works
Ro.co positions itself on the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all. Get Started Online for Just $39
Getting started means online consultation, after which home delivery. Pricing runs on a promotional first month, then standard rate basis, partly published.
On the clinical side, established full-service platform with clinician oversight, prescribing FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables.
Ro.co pros
- Only mainstream platform offering the FDA-approved Wegovy pill, oral GLP-1, no injections
- Get started online for just $39
- FDA-approved finished medication, not compounded
- Established, full-service platform with strong brand trust
Ro.co cons
- Ongoing medication pricing varies and can be high depending on the plan
- Branded and FDA-approved medications cost significantly more than compounded alternatives
- Less price-competitive than compounded-only platforms for budget-driven patients
The reservation worth holding, particularly next to Gala: an FDA-approved finished medication costs multiples of a compounded vial.
Who each program is actually built for
Choose Gala if:
- you would get real value from a direct-pay model with dose monitoring included rather than sold as an add-on
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- you want the full price in front of you before completing an intake
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
Choose Ro.co if:
- delivery works the way you want it to: home delivery
- you want to start on their timeline: online consultation
- the level of clinical contact suits you: established full-service platform with clinician oversight
- the feature you would actually use: the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all
Honest trade-offs
On price. The monthly gap is 6.4x in Ro.co's favor. Whether that is a saving or a false economy turns on one thing: an FDA-approved finished medication costs multiples of a compounded vial.
On predictability. The pricing structures differ (cheaper per month the longer you commit versus promotional first month, then standard rate), and structure, not headline rate, determines the twelve-month bill.
On access. Gala advertises fully online, no in-office visits and home delivery; Ro.co advertises online consultation and home delivery. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On medication. Gala covers compounded semaglutide and compounded tirzepatide; Ro.co covers FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
What the evidence actually says
Weight loss percentages quoted in telehealth marketing come from trials neither Gala nor Ro.co ran. Here is the source material, and what regulators say alongside it.
Compounded medication occupies a different regulatory category entirely: no approval application, and no FDA verification of what is in the vial, per FDA.
The rules governing which pharmacies may compound, and under what conditions, sit in sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, per FDA.
None of that settles which of these two to use. It does mean the drug is doing the work, and you are choosing who supplies it and on what terms.
Gala vs Ro.co: common questions
Which is cheaper to start, Gala or Ro.co?
Ro.co, at $39 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Is Ro.co cheaper than Gala?
Yes, on the ongoing rate. Ro.co runs $39/mo once promotional pricing ends, against $249/mo at Gala — a difference of 6.4x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Are Gala and Ro.co legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Gala operates on cheaper per month the longer you commit with pricing published upfront, Ro.co on promotional first month, then standard rate, partly published. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
How fast can I start with Gala compared with Ro.co?
Gala advertises fully online, no in-office visits, with home delivery. Ro.co advertises online consultation, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Gala and Ro.co prescribe the same medication?
No. Gala dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application; Ro.co dispenses brand-name, FDA-approved finished medication. That is a regulatory difference rather than a branding one, and it is the main reason the two prices are not directly comparable.
Is Gala or Ro.co better for a first GLP-1 prescription?
For a first prescription, weight support over price. Gala offers more contact (provider check-ins and dose monitoring included), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
The verdict
Ro.co is the cheaper of the two to run at $39/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
Gala's case is a direct-pay model with dose monitoring included rather than sold as an add-on; its cost: the entry price sits above most compounded competitors unless you commit to a longer term.
Get the maintenance-dose price in writing from whichever one you pick. That single question prevents most of the regret in this category.
Keep comparing
- Gala vs IVIM HealthLarge platform vs smaller platform
- Gala vs Start WillowTirzepatide access
- Directmeds vs Ro.coBrand-name vs compounded
- Enhance MD vs Ro.coBrand-name vs compounded
- Hers vs MeasuredBrand-name vs compounded
- Hers vs RefillsBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or Ro.co, and does not sell treatment. Read our ranking methodology.